Skip to main content

Pesticide exposure could speed up the development of Parkinson's disease in people who are prone to the disorder, according to the results of a new study.

The study, involving lab mice, examined the effects of low-level exposure to dieldrin, a banned pesticide. The results point to brain changes that could advance Parkinson's disease.

"Our current study shows that pesticides such as dieldrin appear to accelerate or exacerbate the already underlying disease," the research team concluded in a statement released at a recent meeting of the American Chemical Society in San Francisco.

Story continues below advertisement

"Pesticides aren't necessarily the causative agents, but they do promote Parkinson's. So it appears the more you are exposed to pesticides, the greater your risk of development of the disease earlier in life."

Parkinson's disease is characterized by tremors, stiffness and slowness of movement. It results from the gradual death of brain cells that produce dopamine, a chemical that plays a key role in smooth muscle movements.

"We think pesticides in the brain tissue increase oxidative damage and alter dopamine handling," one of the researchers, Kurt Pennell of the Georgia Institute of Technology, said in an e-mail.

Although no longer in use, dieldrin can persist in the environment for decades and move up through the food chain -- particularly in dairy products and meats -- to humans, Dr. Pennell said.

This is not first time that chemicals have been implicated in the development of Parkinson's disease. A study released earlier this year also suggested that chronic exposure to pesticides and herbicides could damage dopamine-producing brain cells.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

If your comment doesn't appear immediately it has been sent to a member of our moderation team for review

Read our community guidelines here

Discussion loading…

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.